Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Retreatments With Intravitreal Bevacizumab

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* \* Any visual acuity~  * OCT: Central foveal thickness greater than 300 u or with evidence of subretinal fluid.~ * Active angiogram leakage~Exclusion Criteria:~* \* Basal Inflammatory disease~  * Endoftalmitis history~ * Lesions bigger than 5400 u or with scarring greater than 50% of lesion.

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: 95 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).